In rs2241766, the absence of the GG genotype in the breast cancer group supports the notion that TG and TG+GG genotypes confer protection against DIBC, a consequence perhaps related to the higher levels of serum adiponectin exhibited by carriers of the GG genotype [35,37,38]. This evidence concerns the gene ADIPOQ and breast cancer.